At Lilly, we unite caring with discovery to make life better for people around the world. We are a global healthcare leader headquartered in Indianapolis, Indiana. Our 35,000 employees around the world work to discover and bring life-changing medicines to those who need them, improve the understanding and management of disease, and give back to our communities through philanthropy and volunteerism. We give our best effort to our work, and we put people first. We’re looking for people who are determined to make life better for people around the world.

At Lilly, we serve an extraordinary purpose. We make a difference for people around the globe by discovering, developing and delivering medicines that help them live longer, healthier, more active lives. Not only do we deliver breakthrough medications, but you also can count on us to develop creative solutions to support communities through philanthropy and volunteerism.

Our common purpose of making medicines that improve lives is what drives our research teams. We are seeking candidates for dynamic position leading a multifaceted group of ADME scientists focused on the ADME/PK support of biologics and hybrid modalities. This is a new and evolving field, so the successful candidate must have not only an established history of people management and scientific leadership, but also a collaborative and innovative approach to challenge historical workflows and drive a new standard of excellence. Lilly is committed to incorporating novel modalities in drug discovery and delivery. Are you ready to join a company and team working to positively impact the lives of patients and our communities? Apply today and become a part of the Lilly family!

Responsibilities

• Lead a group of research path scientific staff with ADME/PK responsibilities across therapeutic areas and across early discovery through late development stages of drug development.
• Provide scientific and administrative leadership. Allocate and prioritize resources, collaborate on scientific and business issues
• Review and approve Drug Disposition study designs, regulatory reports, methods, standard operating procedures and other documents sent externally
• Review Drug Disposition global regulatory submission documents and responses, Tox/Drug Disposition plans, data packages prepared for internal governance committees and in license / out license data packages for content and quality
• Represent ADME on cross functional critical initiatives
• Evaluate new technologies, techniques, study designs or equipment and assess the applicability to current or future functional area needs

Basic Qualification Requirements:

• PhD in scientific field preferably related to drug metabolism and pharmacokinetics (DMPK) or pharmaceutical sciences
• 5+ years job experience in DMPK-related field

Additional Preferences:

• Prior group leadership/people management experience
• Experience with drug discovery and/or development and knowledge of regulatory processes
• Proficient written and spoken English language skills and effective verbal communication
• Experience with PK/drug disposition of one or more of the following: biologics, peptides, siRNA, gene therapies
• Experience with small molecule ADME/PK

Eli Lilly and Company, Lilly USA, LLC and our wholly owned subsidiaries (collectively “Lilly”) are committed to help individuals with disabilities to participate in the workforce and ensure equal opportunity to compete for jobs. If you require an accommodation to submit a resume for positions at Lilly, please email Lilly Human Resources ( Lilly_Recruiting_Compliance@lists.lilly.com ) for further assistance. Please note This email address is intended for use only to request an accommodation as part of the application process. Any other correspondence will not receive a response.

Lilly is an EEO/Affirmative Action Employer and does not discriminate on the basis of age, race, color, religion, gender, sexual orientation, gender identity, gender expression, national origin, protected veteran status, disability or any other legally protected status.

As a condition of employment with Eli Lilly and Company and its subsidiaries in the United States and Puerto Rico, you must be fully COVID-19 vaccinated and provide proof of vaccination satisfactory to the company (subject to applicable law).